BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23518936)

  • 1. Clinical and echocardiographic follow-up in pregnant patients with valvular heart disease.
    Gümrükçüoğlu HA; Güler A; Odabaşı D; Şimşek H; Şahin M; Akdağ S; Karapınar H; Akyol A; Güneş Y; Tuncer M
    Turk Kardiyol Dern Ars; 2013 Jan; 41(1):31-7. PubMed ID: 23518936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of valvular heart disease on maternal and fetal outcome of pregnancy.
    Hameed A; Karaalp IS; Tummala PP; Wani OR; Canetti M; Akhter MW; Goodwin I; Zapadinsky N; Elkayam U
    J Am Coll Cardiol; 2001 Mar; 37(3):893-9. PubMed ID: 11693767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome.
    Leśniak-Sobelga A; Tracz W; KostKiewicz M; Podolec P; Pasowicz M
    Int J Cardiol; 2004 Mar; 94(1):15-23. PubMed ID: 14996469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doppler gradients, valve area and ventricular function in pregnant women with aortic or pulmonary valve disease: Left versus right.
    Siegmund AS; Pieper PG; Mulder BJM; Sieswerda GT; van Dijk APJ; Roos-Hesselink JW; Jongbloed MRM; Konings TC; Bouma BJ; Groen H; Sollie-Szarynska KM; Kampman MAM; Bilardo CM; van Veldhuisen DJ; Aalberts JJJ
    Int J Cardiol; 2020 May; 306():152-157. PubMed ID: 31785953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical treatment of infective endocarditis with vegetations in pregnant women and the outcomes of gestation].
    Chu L; Zhang J; Li YN; Meng X; Liu YY
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):331-8. PubMed ID: 27256439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten Years' Experience of Pregnancy Outcomes in Women with Cardiac Valvulopathies: Are Valve Prostheses Worst?
    Monteiro AV; Rebelo J; Patricio L; Campos A; Borges A; Ferreira RC
    J Heart Valve Dis; 2015 May; 24(3):368-75. PubMed ID: 26901914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
    Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.
    Gardezi SKM; Myerson SG; Chambers J; Coffey S; d'Arcy J; Hobbs FDR; Holt J; Kennedy A; Loudon M; Prendergast A; Prothero A; Wilson J; Prendergast BD
    Heart; 2018 Nov; 104(22):1832-1835. PubMed ID: 29794244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis.
    Ducas RA; Javier DA; D'Souza R; Silversides CK; Tsang W
    Heart; 2020 Apr; 106(7):512-519. PubMed ID: 32054673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital heart disease and acquired valvular lesions in pregnancy].
    Horstkotte D; Fassbender D; Piper C
    Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
    Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Risk Stratification for Cardiac Events in Pregnant Women With Valvular Heart Disease.
    Pande SN; Yavana Suriya J; Ganapathy S; Pillai AA; Satheesh S; Mondal N; Harichandra Kumar KT; Silversides C; Siu SC; D'Souza R; Keepanasseril A
    J Am Coll Cardiol; 2023 Oct; 82(14):1395-1406. PubMed ID: 37758434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of stress echocardiography for valvular heart disease.
    Kusunose K
    J Med Ultrason (2001); 2020 Jan; 47(1):81-89. PubMed ID: 31289972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular heart disease in pregnancy: maternal and fetal outcome.
    Akhter N; Rahman F; Salman M; Anam K; Begum N; Naher S; Fatema N; Hasan Z; Rashid MA; Benerjee SK
    Mymensingh Med J; 2011 Jul; 20(3):436-40. PubMed ID: 21804508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
    Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
    BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy in women with heart disease in sub-Saharan Africa.
    Diao M; Kane A; Ndiaye MB; Mbaye A; Bodian M; Dia MM; Sarr M; Kane A; Monsuez JJ; Ba SA
    Arch Cardiovasc Dis; 2011; 104(6-7):370-4. PubMed ID: 21798468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.